An interventional study of pulsed electromagnetic field and Antibiotics in Osteomyelitis, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 5 Years to 16 Years. Per ClinicalTrials.gov, last updated 2023-11-28.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
This study will be applied to evaluate effect of pulsed electromagnetic field on pediatric localized osteomyelitis.
Twenty (11 girls, 9 boys) patients will participate in this study. Their ages ranged from 5 to 16 years. They will randomly divide into two groups. Group A ( study group) will receive pulsed electromagnetic field in addition to medical treatment three times per week for two months , Group B(control group ) will receive medical treatment only.
105 studies on the registry are indexed under Osteomyelitis; 30 are open to participants now.
This study's planned enrollment of 20 is below the median of 74 across 60 interventional studies indexed under Osteomyelitis.
Browse Osteomyelitis studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
pulsed electromagnetic field and medical treatment ( vancomycin IV injection 1gm divided 250mg every 6hours )
Device: pulsed electromagnetic field · Drug: Antibiotics
medical treatment only (vancomycin IV injection 1gm divided 250mg every 6hours )
Drug: Antibiotics
pulsed electromagnetic field will be over the site of osteomyelitis where patient in supine lying position. the treatment parameters will be set as10 HZ frequency , 20 gauss amplitude, duration about 120 minutes.
Also known as: CRYOMAG PROFESSIONAL.LEVEL,s.r.l
Vancomycin IV injection 1gm divided 250mg every 6hours
Changing of osteomyelitis signs
through CT scan
Time frame: pre treatment and post two months of treatment
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Nov 2023; primary completion for Dec 2023, 1 month later.
Of 21 interventional studies with no phase under Osteomyelitis, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 69. This study's planned 1 month is below that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.